Emily Wearne

FDA Approval Summary: Sotorasib for <i>KRAS G12C</i> -Mutated Metastatic NSCLC

Erica C. Nakajima, Nicole Drezner, Xiaoxue Li et al. · Clinical Cancer Research · 2021 · 305 citations · Full text

Medicine, Oncology, Pharmacology +13

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With <i>RET</i> Gene Mutations or Fusions

Janice Kim, Diana Bradford, Erin Larkins et al. · Clinical Cancer Research · 2021 · 100 citations

Medicine, Molecular Medicine, Oncology +13

FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations

Katie Chon, Erin Larkins, Somak Chatterjee et al. · Clinical Cancer Research · 2023 · 56 citations · Full text

Medicine, Oncology, Pharmacology +15

FDA Approval Summary: TAS-102

Leigh Marcus, Steven J. Lemery, Sachia G. Khasar et al. · Clinical Cancer Research · 2017 · 55 citations · Full text

Medicine, Oncology, Pharmacology +7

An FDA oncology analysis of immune activating products and first-in-human dose selection

Haleh Saber, Ramadevi Gudi, Michael L. Manning et al. · Regulatory Toxicology and Pharmacology · 2016 · 52 citations

Medicine, Immunology, Oncology +15